Which Factors Predict Thrombotic Events in Essential Thrombocythemia?
The risk for disease progression, thrombosis, and mortality in essential thrombocythemia can be predicted with “readily available” patient information.
Read MoreAug 25, 2024
The risk for disease progression, thrombosis, and mortality in essential thrombocythemia can be predicted with “readily available” patient information.
Read MoreAug 24, 2024
Steatotic liver disease shows no impact on clinical outcomes for patients with essential thrombocythemia and polycythemia.
Read MoreAug 23, 2024
Plasma protein profiling can help discern systemic mastocytosis subtypes.
Read MoreAug 22, 2024
Matched sibling donors aside, donor type was not associated with significant differences in overall survival in patients with myelofibrosis who underwent hematopoietic cell transplantation (HCT), according to study results...
Read MoreAug 20, 2024
Risk factors for bleeding and thrombosis among patients with myeloproliferative neoplasms (MPNs) who are scheduled for surgery are multifaceted and require consideration of individual patient characteristics, risk assessment,...
Read More